These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
168 related articles for article (PubMed ID: 2157060)
41. Isolation of a pathogenic clone of mouse mammary tumor virus. Morris DW; Bradshaw HD; Billy HT; Munn RJ; Cardiff RD J Virol; 1989 Jan; 63(1):148-58. PubMed ID: 2535722 [TBL] [Abstract][Full Text] [Related]
42. Acceleration of mouse mammary tumor virus-induced murine mammary tumorigenesis by a p53 172H transgene: influence of FVB background on tumor latency and identification of novel sites of proviral insertion. Chatterjee G; Rosner A; Han Y; Zelazny ET; Li B; Cardiff RD; Perkins AS Am J Pathol; 2002 Dec; 161(6):2241-53. PubMed ID: 12466138 [TBL] [Abstract][Full Text] [Related]
44. Spontaneous progression of hyperplastic outgrowths of the D1 lineage to mammary tumors: expression of mouse mammary tumor virus and cellular proto-oncogenes. Knepper JE; Kittrell FS; Medina D; Butel JS Mol Carcinog; 1989; 1(4):229-38. PubMed ID: 2551332 [TBL] [Abstract][Full Text] [Related]
45. Protoneoplasia: the molecular biology of murine mammary hyperplasia. Cardiff RD Adv Cancer Res; 1984; 42():167-90. PubMed ID: 6098147 [TBL] [Abstract][Full Text] [Related]
46. Many tumors induced by the mouse mammary tumor virus contain a provirus integrated in the same region of the host genome. Nusse R; Varmus HE Cell; 1982 Nov; 31(1):99-109. PubMed ID: 6297757 [TBL] [Abstract][Full Text] [Related]
47. Transgenes expressing the Wnt-1 and int-2 proto-oncogenes cooperate during mammary carcinogenesis in doubly transgenic mice. Kwan H; Pecenka V; Tsukamoto A; Parslow TG; Guzman R; Lin TP; Muller WJ; Lee FS; Leder P; Varmus HE Mol Cell Biol; 1992 Jan; 12(1):147-54. PubMed ID: 1530875 [TBL] [Abstract][Full Text] [Related]
48. A putative int domain for mouse mammary tumor virus on mouse chromosome 7 is a 5' extension of int-2. Peters G; Brookes S; Placzek M; Schuermann M; Michalides R; Dickson C J Virol; 1989 Mar; 63(3):1448-50. PubMed ID: 2536846 [TBL] [Abstract][Full Text] [Related]
49. Wnt-3, a gene activated by proviral insertion in mouse mammary tumors, is homologous to int-1/Wnt-1 and is normally expressed in mouse embryos and adult brain. Roelink H; Wagenaar E; Lopes da Silva S; Nusse R Proc Natl Acad Sci U S A; 1990 Jun; 87(12):4519-23. PubMed ID: 2162045 [TBL] [Abstract][Full Text] [Related]
50. Demonstration of a new mouse mammary tumor virus locus in the genome of the mammary tumor prone strain SHN mouse. Koizumi A; Tsukada M; Wada Y; Kamiyama S Biochem Biophys Res Commun; 1990 Jan; 166(1):336-41. PubMed ID: 2154203 [TBL] [Abstract][Full Text] [Related]
51. The int genes in mouse mammary tumorigenesis and in normal development. Nusse R Ciba Found Symp; 1990; 150():212-22; discussion 222-6. PubMed ID: 2164908 [TBL] [Abstract][Full Text] [Related]
52. Keratinocyte growth factor induces mammary and prostatic hyperplasia and mammary adenocarcinoma in transgenic mice. Kitsberg DI; Leder P Oncogene; 1996 Dec; 13(12):2507-15. PubMed ID: 9000125 [TBL] [Abstract][Full Text] [Related]
53. c-H-ras-1 expression in 7,12-dimethyl benzanthracene-induced Balb/c mouse mammary hyperplasias and their tumors. Cardiff RD; Gumerlock PH; Soong MM; Dandekar S; Barry PA; Young LJ; Meyers FJ Oncogene; 1988 Aug; 3(2):205-13. PubMed ID: 2842717 [TBL] [Abstract][Full Text] [Related]
54. Tumorigenesis by mouse mammary tumor virus: evidence for a common region for provirus integration in mammary tumors. Peters G; Brookes S; Smith R; Dickson C Cell; 1983 Jun; 33(2):369-77. PubMed ID: 6305506 [TBL] [Abstract][Full Text] [Related]
55. Preneoplastic mammary tumor markers: Cripto and Amphiregulin are overexpressed in hyperplastic stages of tumor progression in transgenic mice. Niemeyer CC; Spencer-Dene B; Wu JX; Adamson ED Int J Cancer; 1999 May; 81(4):588-91. PubMed ID: 10225449 [TBL] [Abstract][Full Text] [Related]
56. Differentiation-dependent expression of provirus-activated int-1 oncogene in clonal cell lines derived from a mouse mammary tumor. Schuuring E; van der Leede BJ; Willems R; Daams H; van der Valk M; van de Vijver M; van Leeuwen F; Sonnenberg A; Nusse R Oncogene; 1990 Apr; 5(4):459-65. PubMed ID: 2326076 [TBL] [Abstract][Full Text] [Related]
57. Fgf10 is an oncogene activated by MMTV insertional mutagenesis in mouse mammary tumors and overexpressed in a subset of human breast carcinomas. Theodorou V; Boer M; Weigelt B; Jonkers J; van der Valk M; Hilkens J Oncogene; 2004 Aug; 23(36):6047-55. PubMed ID: 15208658 [TBL] [Abstract][Full Text] [Related]
58. Mode of proviral activation of a putative mammary oncogene (int-1) on mouse chromosome 15. Nusse R; van Ooyen A; Cox D; Fung YK; Varmus H Nature; 1984 Jan 12-18; 307(5947):131-6. PubMed ID: 6318122 [TBL] [Abstract][Full Text] [Related]
59. Two proto-oncogenes implicated in mammary carcinogenesis, int-1 and int-2, are independently regulated during mouse development. Jakobovits A; Shackleford GM; Varmus HE; Martin GR Proc Natl Acad Sci U S A; 1986 Oct; 83(20):7806-10. PubMed ID: 2429320 [TBL] [Abstract][Full Text] [Related]
60. A congenic line of the DDD mouse strain, DDD/1-Mtv-2/Mtv-2: establishment and mammary tumorigenesis. Matsuzawa A; Sayama K; Tsubura A; Murakami A Jpn J Cancer Res; 1990; 81(6-7):639-44. PubMed ID: 1976120 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]